NCT02070068

Brief Summary

Operations on the liver, bile ducts, and gallbladders are some of the most commonly performed abdominal operations in the United States. Cholecystectomy, removal of the gallbladder, is the most common of these with more than 750,000 performed annually. Injury to the common bile duct (CBD) during these procedures occur infrequently (approximately 0.1% to 0.5%), but it is an important source of patient morbidity. Serious injuries often require at least one surgical repair, and these repairs have variable long-term outcomes. Techniques to allow the visualization of the bile ducts may prevent such an injury, by providing vital information about the presence of gallstones in the CBD and show a surgical road map of the ducts. Near-infrared (NIR) cholangiography has the advantage over standard cholangiography of not exposing patients and healthcare providers to radiation. This technique also allows the superimposition of the cholangiogram onto the normal image. This study is being conducted to optimize an imaging technique called PINPOINT. Images will be obtained during clinically necessary operations. The images will be evaluated to determine the best method for locating and outlining the anatomy. The information learned will guide the future use of PINPOINT in laparoscopic procedures.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
38

participants targeted

Target at P50-P75 for early_phase_1

Timeline
Completed

Started Jan 2014

Shorter than P25 for early_phase_1

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2014

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

February 19, 2014

Completed
5 days until next milestone

First Posted

Study publicly available on registry

February 24, 2014

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2014

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2014

Completed
Last Updated

December 2, 2014

Status Verified

December 1, 2014

Enrollment Period

10 months

First QC Date

February 19, 2014

Last Update Submit

December 1, 2014

Conditions

Outcome Measures

Primary Outcomes (2)

  • Ease of Identification of Biliary Anatomy as Scored by the Surgeon (1-5 scale)

    10 minutes after injection

  • Ease of Identification of Biliary Anatomy as Scored by the Surgeon (1-5 scale)

    45 minutes after injection

Study Arms (2)

Group 1

EXPERIMENTAL

ICG administered 10 minutes prior to time of visualization

Device: PINPOINT System

Group 2

EXPERIMENTAL

ICG administered 45 min prior to time of visualization

Device: PINPOINT System

Interventions

Group 1Group 2

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • To be eligible for the study, subjects must fulfill all of the following criteria:
  • Subjects who are healthy men or women 18 years of age or older.
  • Subjects who are scheduled for laparoscopic biliary or hepatic operations.
  • Subjects who sign an approved informed consent form for the study.
  • Subjects who are willing to comply with the protocol.

You may not qualify if:

  • Subjects meeting any of the following criteria will be excluded from the study:
  • Subjects with a known allergy or history of adverse reaction to ICG, iodine or iodine dyes.
  • Subjects who, in the Investigator's opinion, have any medical condition that makes the subject a poor candidate for the investigational procedure, or interferes with the interpretation of study results.
  • Subjects who are pregnant or lactating females.
  • Subjects, who are actively participating in another investigational clinical study and who, in the Investigator's or Sponsor's opinion, should not be enrolled in this study.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Ronald Reagan UCLA Medical Center

Los Angeles, California, 90095, United States

Location

Study Design

Study Type
interventional
Phase
early phase 1
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor

Study Record Dates

First Submitted

February 19, 2014

First Posted

February 24, 2014

Study Start

January 1, 2014

Primary Completion

November 1, 2014

Study Completion

November 1, 2014

Last Updated

December 2, 2014

Record last verified: 2014-12

Locations